News

Redefining Botswana lymphoma characterization, assessment, and treatment in Botswana

9/17/2013

Redefining Botswana lymphoma characterization, assessment, and treatment in Botswana

9/17/2013

Investigator: Dr. Bruce Chabner
Institution: Massachusetts General/Harvard University
Project Title: Redefining Lymphoma Characterization, Assessment and Treatment in Botswana
Award Amount: $850,000 (2013)

This Allen Distinguished Investigator Award will go to support the Botswana Lymphoma Research Project, an effort designed to address the high occurrence of lymphoma affecting AIDS patients in Botswana. Botswana has the second highest AIDS infection rate in the world, which has contributed to a marked increase in cancers including lymphoma. The project will provide the basic research that is necessary to better understand the disease and treatment options.

Researchers involved in this effort will use an existing tumor registry to assess data ranging from incidence, demographics, treatment patterns, and outcomes of lymphoma in Botswana, and obtain pathology specimens for additional reasearch and analysis. They will also identify and further characterize patient tumor subtypes, and then administer develop protocols for treatment.

This work is leveraging strong relationships with the Ministry of Health, School of Medicine, the Botswana Harvard AIDS Institute Partnership, Massachusetts General Hospital, as well as partnerships with the Botswana Princess Marina Hospital, the Gaborone Private Hospital, the Nyangabwe Referral Hospital and the National Health Laboratory.